Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 2, 2006, Pages 192-196

  Yamada, Masakazu ^a,b   Ishikawa, Kaoru ^a   Mochizuki, Hiroshi ^a,b   Kawai, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Cornea; Fluoroquinolones; High performance liquid chromatography; Levofloxacin

Indexed keywords

LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CROSSOVER PROCEDURE; DRUG PENETRATION; DRUG RETENTION; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; KERATOCONUS; KERATOPATHY; MALE; PENETRATING KERATOPLASTY; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; FEMALE; FLUOROQUINOLONES; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; NORFLOXACIN; OFLOXACIN; QUINOLONES; TISSUE DISTRIBUTION;

EID: 33645467703     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00561.x     Document Type: Article

References (21)

1. Chin NX, Novelli A & Neu NC (1988): In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents Chemother 32: 656-662.
2. DeSantis LM (1994): Pharmacokinetics. In: Mayger TF & Craig EL (eds). Havener's Ocular Pharmacology. 6th edn. St. Louis: Mosby-Year Book, Inc. 22-52.
3. Diamond JP, White L, Leeming JP, Hoh HB & Easty DL (1995): Topical 0.3% ciprofloxacin, norfloxacin and ofloxacin in treatment of bacterial keratitis: A new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol 79: 606-609.
4. Donnenfeld ED, Perry HD, Snyder RW, Moadel R, Elsky M & Jones H (1997): Intracorneal, aqueous humour and vitreous humour penetration of topical and oral ofloxacin. Arch Ophthalmol 115: 173-176.
5. Ernst ME, Ernst EJ & Klepser ME (1997): Levofloxacin and trovafloxacin: The next generation of fluoroquinolones? Am J Health-Syst Pharm 54: 2569-2584.
6. Hyndiuk RA, Eiferman RA, Caldwell DR et al. (1996): Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology 103: 1854-1862.
7. Kawashima Y, Takashina H & Usui M (1995): Pharmacokinetic parameters of ofloxacin and levofloxacin ophthalmic solutions. [In Japanese.] Atarasii Ganka 12: 791-794.
8. Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK & Gordon YJ (2001): An in vitro resistance study of levofloxacin, ciprofloxacin and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology 108: 1826-1829.
9. Leibowitz HM (1991): Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 112: 34-47.
10. McDermott ML, Tran TD, Cowden JW & BuggéCJL (1993): Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology 100: 197-200.
11. Neu HC (1991): Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 112: 15-24.
12. O'Brien TP (1997): Bacterial keratitis. In: Krachmer JH, Mannis MJ & Holland EJ (eds). Cornea: Cornea and External Disease: Clinical Diagnosis and Management. St. Louis: Mosby-Year Book, Inc. 1139-1190.
13. O'Brien TP, Maguire MG, Fink NE, Alfonso E & McDonnell P (1995): Efficacy of ofloxacin versus cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 113: 1257-1265.
14. Ogawa GS & HNndiuk RA (1993): The fluoroquinolones: new antibiotics in ophthalmology. Int Ophthalmol Clin 33: 59-68.
15. Ozturk F, Kortunay S, Kurt E, Inan UU, Ilker SS, Basci N & Bozkurt A (1999): The effect of longterm use and inflammation on the ocular penetration of topical ofloxacin. Curr Eye Res 19: 461-464.
16. Price FW, Whitson WE, Gonzales J & Johns S (1997): Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg 23: 898-902.
17. Ross DL & Riley CM (1990): Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharma 63: 237-250.
18. Une T, Fujimoto T, Sato K & Osada Y (1988): In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother 32: 1336-1340.
19. Wimer SMA Schoonover L & Garrison MW (1998): Levofloxacin: a therapeutic review. Clin Ther 20: 1049-1070.
20. Yamada M, Mochizuki H, Yamada K, Kawai M & Mashima Y (2002): Aqueous humour levels of topically applied levofloxacin in human eyes. Curr Eye Res 24: 403-406.
21. Yamada M, Mochizuki H, Yamada K, Kawai M & Mashima Y (2003): Aqueous humour levels of topically applied levofloxacin, norfloxacin and lomefloxacin in the same human eyes. J Cataract Refract Surg 29: 1771-1775.